Table 1.

Clinical characteristics of human subjects

	Control transplant patients (n=30)		AbMR Patients (n=9)	P
Age, mean (SD), y	51.8 (14.4)		38.9 (14.9)	0.025
Male, n (%)	17 (56.7)		3 (33.3)	0.15
Years since transplant, mean (SD)	8.2 (7.0)		2.15 (2.0)	0.0002
Any DSA MFI >500, n (%)	9 (30)		9 (100)	0.0002
C1q-binding DSA, n (%)***	5 (16.7)		4 (66.7)	0.018
Serum Creatinine, mean (SD), mg/dL	1.6 (0.4)		3.24 (2.9)	0.13
Immunosuppression
CNI, n (%)	30 (100)		9 (100)	1.0
mTORi, n (%)	8 (26.7)		1 (16.7)	0.25
Mycophenolate, n (%)	16 (53.3)		8 (83.3)	0.25
Prednisone, n (%)	27 (90)		8 (83.3)	0.44

^***Samples missing for 3 AbMR subjects for C1q-binding assay